Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e092ba7c0b4f2beba27b6420c0bd2ce |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-00 |
filingDate |
2006-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2011-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f8e5b005a72f6d2f4f50212e843ec30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aaf5ba0a99cbef0030483a3655ca3703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_470248c8b87b91dffc4cf8c8caacdd70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3782042a8d273d8873b7f2546b126f21 |
publicationDate |
2011-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7951961-B2 |
titleOfInvention |
Enantioselective synthesis of pyrrolidines substituted with flavones, and intermediates thereof |
abstract |
The present invention relates to an enantioselective synthesis of (+)-trans enantiomer of pyrrolidines substituted with flavones, represented by Formula 1 or salts thereof, which are inhibitors of cyclin dependant kinases and can be used for treatment of proliferative disorders such as cancer n nwherein Ar has the meaning as indicated in the claims. |
priorityDate |
2006-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |